ANGPTL2 and precursor B-cell acute lymphoblastic leukemia: In this study, we demonstrated that ANGPTL2-containing SEVs released from ECs support B-ALL development while ANGPTL2-mut#2-containing SEVs had no effects on B-ALL progression.